Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

28.07
+2.027.75%
Volume:5.44M
Turnover:149.73M
Market Cap:7.92B
PE:75.46
High:28.42
Open:25.80
Low:25.80
Close:26.05
52wk High:34.54
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:2.93
T/O Rate:4.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:13.38
PE(LYR):-8.72

Loading ...

Caris Life Sciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Caris Life Sciences Q2 Revenue Rises 45% on the Back of Molecular Profiling Services

Reuters
·
Aug 06

Caris Life Sciences Q2 FY26 Net Loss Narrows to USD 0.6 Million; Revenue Rises 45% to USD 263.7 Million

Reuters
·
Aug 06

Caris Life Sciences Q2 Sales $263.712M Beat $238.125M Estimate

Benzinga Earnings
·
Aug 06

Caris Life Sciences Inc Q2 Net Loss Per Share $0.00

THOMSON REUTERS
·
Aug 06

Caris Life Sciences Inc Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 04

Earning Preview: Caris Life Sciences, Inc. Q2 revenue is expected to increase by 74.08%, and institutional views are bullish

Earnings Agent
·
Jul 29

Analysts Offer Insights on NA Companies: Neptune Insurance Holdings, Inc. Class A (NP), Saizeriya Co (OtherSZYCF) and Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
Jul 23

Caris Life Sciences Schedules Second-quarter 2026 Results Webcast

Reuters
·
Jul 16

CAI Corp calls August EGM to approve HK$0.33 share subscription by Longling Capital

TIPRANKS
·
Jul 16

Caris Life Sciences price target lowered to $30 from $31 at TD Cowen

TIPRANKS
·
Jul 15

CAI Corp Reports Unaudited Net Asset Value of HK$0.12 Per Share

TIPRANKS
·
Jul 15

CAI Corp Sets August Board Meeting to Approve Interim Results

TIPRANKS
·
Jul 15

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

TIPRANKS
·
Jul 14

BofA Adjusts Price Target on Caris Life Sciences to $23 From $28

MT Newswires Live
·
Jul 13

Caris Life Sciences Director Jon Halbert Reports Purchase of 68,000 Common Shares Worth $990,080

Reuters
·
Jul 13

Illumina Names Mike Sullivan Chief Commercial Officer Effective July 20

Reuters
·
Jul 09

Caris Life Sciences is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

CAI Corp Delays Circular on New Share Subscription

TIPRANKS
·
Jul 06

Analyst Initiates Buy Rating on Caris, Highlighting Caris Detect Launch and Early Positive Economics

TIPRANKS
·
Jul 02